WFA of San Diego’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,324
Closed -$230K 408
2025
Q4
$230K Hold
1,324
0.17% 88
2025
Q3
$252K Hold
1,324
0.17% 87
2025
Q2
$238K Buy
+1,324
New +$230K 0.18% 84
2023
Q1
Sell
-1,474
Closed -$231K 142
2022
Q4
$231K Buy
+1,474
New +$212K 0.18% 86
2022
Q3
Sell
-150
Closed -$20K 155
2022
Q2
$20K Buy
+150
New +$20.4K 0.02% 220
2022
Q1
Sell
-1,474
Closed -$255K 101
2021
Q4
$255K Buy
+1,474
New +$224K 0.15% 103

Other funds holding DGX

WFA of San Diego's DGX Position: Q1 2026 in Review

WFA of San Diego sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 1,324 shares — an estimated $230K sold.

WFA of San Diego first reported a position in DGX in Q4 2021 and held it in 6 quarters. The position peaked at $255K in Q4 2021. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • WFA of San Diego reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • WFA of San Diego sold 1,324 Quest Diagnostics shares in Q1 2026, an estimated $230K.
  • WFA of San Diego first reported a position in Quest Diagnostics in Q4 2021 and held it in 6 quarters.
  • WFA of San Diego's Quest Diagnostics position peaked at $255K in Q4 2021.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on WFA of San Diego's 13F filing for Q1 2026, filed 11 May 2026.